Celltex Therapeutics is hosting a webinar with Chief Medical Officer Dr. Stanley C. Jones, who will share some overall wellness recommendations and discuss how they may help increase the potential for positive results following stem cell therapy.

Regenerative medicine holds immense potential, and while there are still areas of ongoing research, it is understood that Mesenchymal Stem Cells (MSCs) possess the ability to migrate to sites of inflammation and release bioactive factors that promote the growth, survival, and functionality of surrounding cells.

While results vary, regenerative medicine physicians may recommend additional strategies to reduce systemic inflammation, so that there are fewer inflammatory sites for the MSCs to target.

Renowned orthopedic spine surgeon Dr. Stanley Jones is one of these physicians helping lead the way in regenerative medicine. Having seen stem cell therapy applied in over one hundred different conditions, he has a deep understanding of both its potential and limitations. As Celltex’s Chief Medical Officer, Dr. Jones leverages his extensive experience to evaluate health goals and make recommendations to help improve the chances of positive outcomes.

In this webinar, we’ll sit down with Dr. Jones to discuss some overall wellness recommendations and how they may help increase the potential for positive results following stem cell therapy.

We’ll review the science of stem cells and discuss client-reported data before answering questions during the audience Q&A.

There is no cost to join this webinar. Participants who join the live discussion will have the opportunity to submit questions to be answered by our panel, and registrants will get access to view the recording on-demand.